Category Peripheral T-Cell Lymphoma

Ruth Alonso-Alonso, PhD

Researcher Spotlight: Ruth Alonso-Alonso, PhD THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK Oliver W. Press, MD, PhD Memorial Fellow Angioimmunoblastic T-cell lymphoma (AITL) is an aggressive form of peripheral T-cell lymphoma. Therapeutic options for AITL are…

Zachary Epstein-Peterson, MD

Researcher Spotlight: Zachary Epstein-Peterson, MD MEMORIAL SLOAN KETTERING CANCER CENTER Peripheral T-cell lymphomas are a rare and challenging group of malignancies to treat. Mutations in the isocitrate dehydrogenase 2 (IDH2) enzyme have been identified in a subgroup of patients with…

Neha Mehta-Shah, MD

Researcher Spotlight: Neha Mehta-Shah, MD Washington University in Saint Louis Peripheral T-cell lymphomas (PTCL) are a rare group of lymphomas that are commonly treated with combination chemotherapy, followed by autologous stem cell transplant for patients with a good response. However,…

Jonathan Schatz, MD

Researcher Spotlight: Jonathan Schatz, MD University of MIAMI MILLER SCHOOL OF MEDICINE The Lymphoma Research Foundation (LRF) established its Clinical Investigator Career Development Awards (CDA) to facilitate early career clinical scientists in establishing themselves as independent investigators in lymphoma research.…

Neha Mehta-Shah, MD

Researcher Spotlight: Neha Mehta-Shah, MD Washington University in Saint Louis Dr. Mehta-Shah is Assistant Professor at the Washington University School of Medicine in Saint Louis. Her Lymphoma Clinical Research Mentoring Program (LCRMP) project seeks to develop a method for identifying…